BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murphy GM, Ross A, Billing BH. Serum bile acids in primary biliary cirrhosis. Gut. 1972;13:201-206. [PMID: 5024725 DOI: 10.1136/gut.13.3.201] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Murphy GM, Signer E. Bile acid metabolism in infants and children. Gut 1974;15:151-63. [PMID: 4595082 DOI: 10.1136/gut.15.2.151] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 1.0] [Reference Citation Analysis]
2 Murphy GM. Serum Bile Acids. In: Setchell KDR, Kritchevsky D, Nair PP, editors. The Bile Acids: Chemistry, Physiology, and Metabolism. Boston: Springer US; 1988. pp. 379-403. [DOI: 10.1007/978-1-4613-0901-7_10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
3 Jones EA, Bergasa NV. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology. 1990;11:884-887. [PMID: 2161397 DOI: 10.1002/hep.1840110526] [Cited by in Crossref: 141] [Cited by in F6Publishing: 116] [Article Influence: 4.4] [Reference Citation Analysis]
4 Düll MM, Kremer AE. Treatment of Pruritus Secondary to Liver Disease. Curr Gastroenterol Rep 2019;21. [DOI: 10.1007/s11894-019-0713-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
5 Li X, Xu H, Gao P. Increased red cell distribution width predicts severity of drug-induced liver injury: a retrospective study. Sci Rep 2021;11:773. [PMID: 33436893 DOI: 10.1038/s41598-020-80116-4] [Reference Citation Analysis]
6 Bassari R, Koea JB. Jaundice associated pruritis: A review of pathophysiology and treatment. World J Gastroenterol 2015; 21(5): 1404-1413 [PMID: 25663760 DOI: 10.3748/wjg.v21.i5.1404] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
7 Milstein HJ, Bloomer JR, Klatskin G. Serum bile acids in alcoholic liver disease. Comparison with histological features of the disease. Am J Dig Dis. 1976;21:281-285. [PMID: 1274919 DOI: 10.1007/BF01071839] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
8 Terra SG, Tsunoda SM. Opioid antagonists in the treatment of pruritus from cholestatic liver disease. Ann Pharmacother 1998;32:1228-30. [PMID: 9825091 DOI: 10.1345/aph.18115] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
9 Miettinen TA. Bile Acid Metabolism. In: Kritchevsky D, editor. Hypolipidemic Agents. Berlin: Springer Berlin Heidelberg; 1975. pp. 109-50. [DOI: 10.1007/978-3-642-66190-7_3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
10 Langedijk JAGM, Beuers UH, Oude Elferink RPJ. Cholestasis-Associated Pruritus and Its Pruritogens. Front Med (Lausanne) 2021;8:639674. [PMID: 33791327 DOI: 10.3389/fmed.2021.639674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu T, Wang RX, Han J, Qiu YL, Borchers CH, Ling V, Wang JS. Changes in plasma bile acid profiles after partial internal biliary diversion in PFIC2 patients. Ann Transl Med 2020;8:185. [PMID: 32309332 DOI: 10.21037/atm.2020.01.103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Hanid M, Levi A. PHOTOTHERAPY FOR PRURITUS IN PRIMARY BILIARY CIRRHOSIS. The Lancet 1980;316:530. [DOI: 10.1016/s0140-6736(80)91849-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
13 Hohenester S, Kanitz V, Kremer AE, Paulusma CC, Wimmer R, Kuehn H, Denk G, Horst D, Elferink RO, Beuers U. Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis. Cells 2020;9:E281. [PMID: 31979271 DOI: 10.3390/cells9020281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Simons FE, Watson WT, Chen XY, Minuk GY, Simons KJ. The pharmacokinetics and pharmacodynamics of hydroxyzine in patients with primary biliary cirrhosis. J Clin Pharmacol 1989;29:809-15. [PMID: 2572611 DOI: 10.1002/j.1552-4604.1989.tb03424.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
15 Kremer AE, Martens JJ, Kulik W, Ruëff F, Kuiper EM, van Buuren HR, van Erpecum KJ, Kondrackiene J, Prieto J, Rust C. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010;139:1008-1018, 1018.e1. [PMID: 20546739 DOI: 10.1053/j.gastro.2010.05.009] [Cited by in Crossref: 252] [Cited by in F6Publishing: 213] [Article Influence: 21.0] [Reference Citation Analysis]
16 Gilmore IT, Thompson RP. Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease. Gut 1978;19:1110-5. [PMID: 744496 DOI: 10.1136/gut.19.12.1110] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.5] [Reference Citation Analysis]
17 Edwards JE, LaCerte C, Peyret T, Gosselin NH, Marier JF, Hofmann AF, Shapiro D. Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage. Clin Transl Sci 2016;9:328-36. [PMID: 27743502 DOI: 10.1111/cts.12421] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
18 Sanjel B, Shim WS. Recent advances in understanding the molecular mechanisms of cholestatic pruritus: A review. Biochim Biophys Acta Mol Basis Dis 2020;1866:165958. [PMID: 32896605 DOI: 10.1016/j.bbadis.2020.165958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Heenan P, Mulroney C, Holman C, Armstrong B. FREQUENCY OF THIN MALIGNANT MELANOMA. The Lancet 1980;316:530. [DOI: 10.1016/s0140-6736(80)91850-4] [Cited by in Crossref: 8] [Article Influence: 0.2] [Reference Citation Analysis]
20 Terán A, Fábrega E, Pons-Romero F. [Pruritus associated with cholestasis]. Gastroenterol Hepatol 2010;33:313-22. [PMID: 19836105 DOI: 10.1016/j.gastrohep.2009.07.006] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Murphy GM, Jansen FH, Billing BH. Unsaturated monohydroxy bile acids in cholestatic liver disease. Biochem J 1972;129:491-4. [PMID: 4643332 DOI: 10.1042/bj1290491] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 0.4] [Reference Citation Analysis]
22 Whiting MJ. Bile acids. Adv Clin Chem 1986;25:169-232. [PMID: 3521214 DOI: 10.1016/s0065-2423(08)60126-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Sarkany I. The Skin-Liver Connection. Clin Exp Dermatol 1988;13:151-9. [DOI: 10.1111/j.1365-2230.1988.tb01959.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
24 Nittono H. Studies on the Toxicity of Bile Acids in Infants Part 2. Bile Acid Metabolism and Individual Differences in Premature and Newborn Infants. Pediatr Int 1979;21:25-33. [DOI: 10.1111/j.1442-200x.1979.tb00175.x] [Cited by in Crossref: 6] [Article Influence: 0.1] [Reference Citation Analysis]
25 Kremer AE, Oude Elferink RP, Beuers U. Cholestatic pruritus: new insights into pathophysiology and current treatment. Hautarzt. 2012;63:532-538. [PMID: 22733242 DOI: 10.1007/s00105-011-2321-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Düll MM, Kremer AE. Newer Approaches to the Management of Pruritus in Cholestatic Liver Disease. Curr Hepatology Rep 2020;19:86-95. [DOI: 10.1007/s11901-020-00517-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Jackson JP, Freeman KM, Friley WW, St. Claire RL, Black C, Brouwer KR. Basolateral Efflux Transporters: A Potentially Important Pathway for the Prevention of Cholestatic Hepatotoxicity. Applied In Vitro Toxicology 2016;2:207-16. [DOI: 10.1089/aivt.2016.0023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
28 Luo L, Aubrecht J, Li D, Warner RL, Johnson KJ, Kenny J, Colangelo JL. Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans. PLoS One. 2018;13:e0193824. [PMID: 29513725 DOI: 10.1371/journal.pone.0193824] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 13.5] [Reference Citation Analysis]
29 Imam MH, Gossard AA, Sinakos E, Lindor KD. Pathogenesis and management of pruritus in cholestatic liver disease. J Gastroenterol Hepatol. 2012;27:1150-1158. [PMID: 22413872 DOI: 10.1111/j.1440-1746.2012.07109.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
30 Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, Eskreis D, Katz S. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology 1989;10:414-9. [DOI: 10.1002/hep.1840100404] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 2.2] [Reference Citation Analysis]
31 Kremer AE, Feramisco J, Reeh PW, Beuers U, Oude Elferink RP. Receptors, cells and circuits involved in pruritus of systemic disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014;1842:869-92. [DOI: 10.1016/j.bbadis.2014.02.007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
32 Bergasa NV. Update on the Treatment of the Pruritus of Cholestasis. Clinics in Liver Disease 2008;12:219-34. [DOI: 10.1016/j.cld.2007.11.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
33 Franz B, Bode JC. Total plasma bile acid concentration in chronic hepatitis and cirrhosis; Fasting values and effect of intraduodenal bile salt administration. Klin Wochenschr 1974;52:522-6. [DOI: 10.1007/bf01468722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Bergasa NV. The pruritus of cholestasis. Semin Dermatol 1995;14:302-12. [PMID: 8679436 DOI: 10.1016/s1085-5629(05)80052-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
35 Murphy GM. Serum Bile Acids in Cholestatic Liver Disease: Their Measurement and Significance. Ann Clin Biochem 1972;9:67-73. [DOI: 10.1177/000456327200900137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Bron B, Waldram R, Silk DB, Williams R. Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure. Gut 1977;18:692-6. [PMID: 604189 DOI: 10.1136/gut.18.9.692] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 0.8] [Reference Citation Analysis]
37 Tarikci N, Kocatürk E, Güngör Ş, Topal IO, Can PÜ, Singer R. Pruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment Modalities. ScientificWorldJournal 2015;2015:803752. [PMID: 26240837 DOI: 10.1155/2015/803752] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
38 Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 2010;49:1-11. [PMID: 20465602 DOI: 10.1111/j.1365-4632.2009.04249.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
39 Eisendle K, Müller H, Ortner E, Talasz H, Graziadei I, Vogel W, Höpfl R. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease. J Gastroenterol Hepatol. 2011;26:716-721. [PMID: 21155876 DOI: 10.1111/j.1440-1746.2010.06522.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
40 Kremer AE, Oude Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol. 2011;35:89-97. [PMID: 21809485 DOI: 10.1016/j.clinre.2010.10.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
41 Winkelmann RK. Pharmacologic Control of Pruritus. Medical Clinics of North America 1982;66:1119-33. [DOI: 10.1016/s0025-7125(16)31386-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Stiehl A. Disturbances of Bile Acid Metabolism in Cholestasis. Clinics in Gastroenterology 1977;6:45-67. [DOI: 10.1016/s0300-5089(21)00385-0] [Cited by in Crossref: 22] [Article Influence: 0.5] [Reference Citation Analysis]
43 Miettinen TA. Effects of hypolipidemic drugs on bile acid metabolism in man. Adv Lipid Res 1981;18:65-97. [PMID: 6275661 DOI: 10.1016/b978-0-12-024918-3.50008-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
44 Anakk S, Bhosale M, Schmidt VA, Johnson RL, Finegold MJ, Moore DD. Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 2013;5:1060-1069. [PMID: 24268772 DOI: 10.1016/j.celrep.2013.10.030] [Cited by in Crossref: 112] [Cited by in F6Publishing: 106] [Article Influence: 12.4] [Reference Citation Analysis]
45 Terg R, Coronel E, Sordá J, Muñoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 2002;37:717-22. [PMID: 12445410 DOI: 10.1016/s0168-8278(02)00318-5] [Cited by in Crossref: 113] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
46 Ghent CN, Bloomer JR, Klatskin G. Elevations in Skin Tissue Levels of Bile Acids in Human Cholestasis: Relation to Serum Levels and to Pruritus. Gastroenterology 1977;73:1125-30. [DOI: 10.1016/s0016-5085(19)31870-0] [Cited by in Crossref: 107] [Article Influence: 2.4] [Reference Citation Analysis]
47 Dilger K, Hohenester S, Winkler-Budenhofer U, Bastiaansen BA, Schaap FG, Rust C, Beuers U. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health. J Hepatol. 2012;57:133-140. [PMID: 22414767 DOI: 10.1016/j.jhep.2012.02.014] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 7.5] [Reference Citation Analysis]
48 Dogra S, Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol 2011;1:177-84. [PMID: 25755383 DOI: 10.1016/S0973-6883(11)60235-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
49 Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
50 Back P. Identification and quantitative determination of urinary bile acids excreted in cholestasis. Clin Chim Acta 1973;44:199-207. [PMID: 4699628 DOI: 10.1016/0009-8981(73)90382-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 0.8] [Reference Citation Analysis]
51 Khandelwal M, Malet PF. Pruritus associated with cholestasis. A review of pathogenesis and management. Dig Dis Sci 1994;39:1-8. [PMID: 8281842 DOI: 10.1007/BF02090052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
52 Cerio R, Murphy G, Sladen G, Macdonald D. A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis. Br J Dermatol 1987;116:265-7. [DOI: 10.1111/j.1365-2133.1987.tb05825.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
53 Bergasa NV. Pruritus and fatigue in primary biliary cirrhosis. Clin Liver Dis. 2003;7:879-900. [PMID: 14594135 DOI: 10.1016/s1089-3261(03)00105-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
54 Schaffner F. Primary Biliary Cirrhosis. Clinics in Gastroenterology 1975;4:351-66. [DOI: 10.1016/s0300-5089(21)00118-8] [Cited by in Crossref: 12] [Article Influence: 0.3] [Reference Citation Analysis]
55 van Berge Henegouwen GP, Brandt KH, Eyssen H, Parmentier G. Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis. Gut. 1976;17:861-869. [PMID: 1001976 DOI: 10.1136/gut.17.11.861] [Cited by in Crossref: 142] [Cited by in F6Publishing: 136] [Article Influence: 3.2] [Reference Citation Analysis]
56 Bell GD, Mok HY, Thwe M, Murphy GM, Henry K, Dowling RH. Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid. Gut 1974;15:165-72. [PMID: 4152191 DOI: 10.1136/gut.15.3.165] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 1.1] [Reference Citation Analysis]
57 Kesäniemi YA, Miettinen TA, Salaspuro MP. Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes. Gut 1981;22:579-84. [PMID: 6167493 DOI: 10.1136/gut.22.7.579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
58 Babatin MA, Sanai FM, Swain MG. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Aliment Pharmacol Ther 2006;24:813-20. [PMID: 16918885 DOI: 10.1111/j.1365-2036.2006.03048.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
59 Bergasa NV, Mehlman JK, Jones EA. Pruritus and fatigue in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:643-655. [PMID: 10976020 DOI: 10.1053/bega.2000.0109] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
60 Yanagisawa J, Akashi Y, Miyazaki H, Nakayama F. Critical evaluation of the existence of so-called tissue-bound lithocholate in human liver tissue by selected ion monitoring. Journal of Lipid Research 1984;25:1263-71. [DOI: 10.1016/s0022-2275(20)40778-3] [Cited by in Crossref: 13] [Article Influence: 0.3] [Reference Citation Analysis]
61 Vlahcevic Z, Prugh M, Gregory D, Swell L. Disturbances of Bile Acid Metabolism in Parenchymal Liver Cell Disease. Clinics in Gastroenterology 1977;6:25-43. [DOI: 10.1016/s0300-5089(21)00384-9] [Cited by in Crossref: 21] [Article Influence: 0.5] [Reference Citation Analysis]
62 Hartmann J, Harm S. Removal of bile acids by extracorporeal therapies: an in vitro study. Int J Artif Organs 2017;:0. [PMID: 28885663 DOI: 10.5301/ijao.5000643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
63 Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163-2182. [PMID: 18840005 DOI: 10.2165/00003495-200868150-00006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
64 Matern S, Gerok W. Pathophysiology of the enterohepatic circulation of bile acids. Reviews of Physiology, Biochemistry and Pharmacology, Volume 86. Berlin: Springer Berlin Heidelberg; 1979. pp. 125-204. [DOI: 10.1007/bfb0036117] [Cited by in Crossref: 40] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]